Published : Aug-2017
No. of Pages : 149
Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Neurology Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Neurology Devices Market, Canada 13
3.1 Neurology Devices Market, Canada, Revenue ($m), 2009-2023 13
3.4 Neurology Devices Market, Canada, Revenue ($m), 2009-2016 15
3.5 Neurology Devices Market, Canada, Revenue ($m), 2016-2023 17
3.6 Neurology Devices Market, Canada, Volume (Units), 2009-2023 19
3.7 Neurology Devices Market, Canada, Volume (Units), 2009-2016 21
3.8 Neurology Devices Market, Canada, Volume (Units), 2016-2023 23
3.9 Neurology Devices Market, Canada, Company Share by Revenue ($m), 2016 25
4 CSF Management Market, Canada 27
4.1 CSF Management Market, Canada, Revenue Mix ($m), 2016 27
4.2 CSF Management Market, Canada, Segment Contribution (%), 2016 28
4.3 CSF Management Market, Canada, Revenue ($m), 2009-2016 29
4.4 CSF Management Market, Canada, Revenue ($m), 2016-2023 31
4.5 CSF Management Market, Canada, Volume (Units), 2009-2016 33
4.6 CSF Management Market, Canada, Volume (Units), 2016-2023 35
4.7 CSF Management Market, Canada, Distribution Share by Revenue ($m), 2015-2016 37
4.8 CSF Management Market, Canada, Company Share by Revenue ($m), 2016 38
5 Interventional Neurology Market, Canada 40
5.1 Interventional Neurology Market, Canada, Revenue Mix ($m), 2016 40
5.2 Interventional Neurology Market, Canada, Segment Contribution (%), 2016 41
5.3 Interventional Neurology Market, Canada, Revenue ($m), 2009-2016 42
5.4 Interventional Neurology Market, Canada, Revenue ($m), 2016-2023 44
5.4.1 Embolization and Coiling Devices Market, Canada, Revenue ($m), by Segment, 2009-2016 46
5.4.2 Navigational System Market, Canada, Revenue ($m), by Segment, 2009-2016 48
5.4.3 Embolization and Coiling Devices Market, Canada, Revenue ($m), by Segment, 2016-2023 50
5.4.4 Navigational System Market, Canada, Revenue ($m), by Segment, 2016-2023 52
5.5 Interventional Neurology Market, Canada, Volume (Units), 2009-2016 54
5.6 Interventional Neurology Market, Canada, Volume (Units), 2016-2023 56
5.6.1 Embolization and Coiling Devices Market, Canada, Volume (Units), by Segment, 2009-2016 58
5.6.2 Navigational System Market, Canada, Volume (Units), by Segment, 2009-2016 60
5.6.3 Embolization and Coiling Devices Market, Canada, Volume (Units), by Segment, 2016-2023 62
5.6.4 Navigational System Market, Canada, Volume (Units), by Segment, 2016-2023 64
5.7 Interventional Neurology Market, Canada, Distribution Share by Revenue ($m), 2015-2016 66
5.8 Interventional Neurology Market, Canada, Company Share by Revenue ($m), 2016 67
6 Neurological Diagnostic Equipment Market, Canada 69
6.1 Neurological Diagnostic Equipment Market, Canada, Revenue Mix ($m), 2016 69
6.2 Neurological Diagnostic Equipment Market, Canada, Segment Contribution (%), 2016 70
3.1 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2009-2016 71
3.2 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2016-2023 73
3.3 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2009-2016 75
3.4 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2016-2023 77
3.6 Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), 2015-2016 79
3.7 Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), 2016 80
7 Neurostimulation Devices Market, Canada 82
7.1 Neurostimulation Devices Market, Canada, Revenue Mix ($m), 2016 82
7.2 Neurostimulation Devices Market, Canada, Segment Contribution (%), 2016 83
7.3 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2009-2016 84
7.4 Neurological Diagnostic Equipment Market, Canada, Revenue ($m), 2016-2023 86
7.5 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2009-2016 88
7.6 Neurological Diagnostic Equipment Market, Canada, Volume (Units), 2016-2023 90
7.7 Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), 2015-2016 92
7.8 Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), 2016 93
8 Neurosurgical Products Market, Canada 95
8.1 Neurosurgical Products Market, Canada, Revenue Mix ($m), 2016 95
8.2 Neurosurgical Products Market, Canada, Segment Contribution (%), 2016 96
8.3 Neurosurgical Products Market, Canada, Revenue ($m), 2009-2016 98
8.4 Neurosurgical Products Market, Canada, Revenue ($m), 2016-2023 100
8.5 Neurosurgical Products Market, Canada, Volume (Units), 2009-2016 102
8.6 Neurosurgical Products Market, Canada, Volume (Units), 2016-2023 104
8.7 Neurosurgical Products Market, Canada, Distribution Share by Revenue ($m), 2015-2016 106
8.8 Neurosurgical Products Market, Canada, Company Share by Revenue ($m), 2016 107
9 Radiosurgery Market, Canada 109
9.1 Radiosurgery Market, Canada, Revenue ($m), 2009-2016 109
9.2 Radiosurgery Market, Canada, Volume (Units), 2009-2016 110
10 Overview of Key Companies in Canada, Neurology Devices Market 111
10.1 Medtronic Plc 111
10.1.1 Company Overview 111
10.2 DePuy Synthes Inc 111
10.2.1 Company Overview 111
10.3 Integra LifeSciences Holdings Corp 111
10.3.1 Company Overview 111
10.4 Natus Medical Incorporated 111
10.4.1 Company Overview 111
10.5 Stryker Corporation 112
10.5.1 Company Overview 112
10.6 B. Braun Melsungen AG 112
10.6.1 Company Overview 112
10.7 Boston Scientific Corp 112
10.7.1 Company Overview 112
10.8 St. Jude Medical LLC 112
10.8.1 Company Overview 112
10.9 Nihon Kohden Corp 113
10.9.1 Company Overview 113
10.10 LivaNova PLC 113
10.10.1 Company Overview 113
11 Neurology Devices Market Pipeline Products 114
12 Financial Deals Landscape 118
12.1 Debt Offerings 118
12.1.1 M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019 118
12.2 Equity Offerings 119
12.2.1 Sierra Oncology Prices Public Offering of Shares for USD26.3 Million 119
12.3 Partnerships 121
12.3.1 Colorado State University and Synaptive Medical Enter into Partnership 121
12.4 Private Equity 122
12.4.1 General Atlantic Invests in Synaptive Medical 122
12.5 Venture Financing 123
12.5.1 Evasc Medical Systems Raises USD7.5 Million in Series A Financing 123
12.5.2 Synaptive Medical Raises USD1 Million in Venture Financing 124
12.5.3 NeuroQore Secures Venture Funding from IndieBio 125
12.5.4 Synaptive Medical Raises Additional USD0.3 Million in Venture Financing 126
12.5.5 Synaptive Medical Raises USD3.4 Millio in Venture Financing 127
13 Recent Developments 128
13.1 Corporate Communications 128
13.1.1 Mar 23, 2017: Synaptive Medical Expands Medtech Expertise Through Board Additions 128
13.1.2 Jan 09, 2017: New Study Shows 3D Signatures' Telomere Analysis May Be an Effective Biomarker for Monitoring High Risk Prostate Cancer Patients 129
13.2 Financial Announcements 130
13.2.1 May 09, 2017: Sierra Oncology Reports First Quarter 2017 Results 130
13.2.2 Mar 15, 2017: Prima BioMed Completes Recruitment for Second Patient Cohort in Melanoma Trial and Will Present at ICI Conference in Boston 130
13.2.3 Mar 02, 2017: Sierra Oncology Reports 2016 Year-End Results 132
13.2.4 Feb 28, 2017: Results for the second quarter of Fiscal year 2017 - Ergoresearch reports its results for the quarter ended December 31, 2016 134
13.2.5 Nov 28, 2016: Results for the first quarter of Fiscal year 2017 - Ergoresearch reports its results for the quarter ended 134
13.2.6 Nov 28, 2016: Ergoresearch reports its results for the quarter ended September 30, 2016 135
13.2.7 Oct 28, 2016: Results for the fourth quarter and the fiscal year ended June 30, 2016 - Ergoresearch reports its 2016 annual results 135
13.3 Legal And Regulatory 136
13.3.1 May 23, 2017: KARL STORZ Wins Inter Partes Review Trial Invalidating Novadaq Patent 136
13.3.2 Feb 03, 2017: Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been Received For February 16th Product Launch in Puerto Vallarta, Mexico 136
13.3.3 Jan 09, 2017: ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs 137
13.3.4 Jul 06, 2016: U.S. patent trial and appeal board grants ZEISS' petition and institutes IPR against NPE patent holder AMI 137
13.4 Other Significant Developments 138
13.4.1 May 02, 2017: University of Oklahoma Medical Center First in State to Acquire Advanced Technology for Brain Surgery 138
13.4.2 Apr 10, 2017: Rapid blood test for intracranial hemorrhage in well appearing infants: a comprehensive brain injury study using Axela's Flow-Thru Chip platform 138
13.4.3 Feb 28, 2017: Government of Canada Invests in Research to Advance Patient Care 139
13.4.4 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions 140
13.5 Product News 141
13.5.1 Nov 08, 2016: Medtronic the first to offer complete portfolio of full-body MR conditional neurostimulation systems for chronic pain in Canada 141
13.5.2 Oct 26, 2016: Synaptive Medical to Showcase BrightMatter Technology at North American Spine Society in Boston 142
13.5.3 Aug 31, 2016: Scientists discover non-invasive technique to monitor migraines 142
13.5.4 Jul 15, 2016: Alzheimer's Association International Conference 2016 143
13.5.5 Jul 08, 2016: Canadian company gives hope to Alzheimer's sufferers with wearable low-level light therapy 143
14 Appendix 145
14.1 Research Methodology 146
14.1.1 Coverage 146
14.1.2 Secondary Research 146
14.1.3 Primary Research 147
14.1.4 Company Share Analysis 147
14.1.5 Distribution Share Analysis 147
14.1.6 Benchmarking 148
14.2 GlobalData Consulting 148
14.3 Contact Us 149
14.4 Disclaimer 149
1.1 List of Tables
Table 1: Neurology Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023 14
Table 2: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 16
Table 3: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Table 4: Neurology Devices Market, Canada, Volume (Units), 2009-2023 20
Table 5: Neurology Devices Market, Canada, Volume (Units), Historic, 2009-2016 22
Table 6: Neurology Devices Market, Canada, Volume (Units), Forecast, 2016-2023 24
Table 7: Neurology Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 26
Table 8: CSF Management Market, Canada, Segment Contribution (%), 2016 28
Table 9: CSF Management Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 30
Table 10: CSF Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Table 11: CSF Management Market, Canada, Volume (Units), Historic, 2009-2016 34
Table 12: CSF Management Market, Canada, Volume (Units), Forecast, 2016-2023 36
Table 13: CSF Management Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 37
Table 14: CSF Management Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 39
Table 15: Interventional Neurology Market, Canada, Segment Contribution (%), 2016 41
Table 16: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 43
Table 17: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 45
Table 18: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 47
Table 19: Navigational System Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 49
Table 20: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 51
Table 21: Navigational System Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Table 22: Interventional Neurology Market, Canada, Volume (Units), Historic, 2009-2016 55
Table 23: Interventional Neurology Market, Canada, Volume (Units), Forecast, 2016-2023 57
Table 24: Embolization and Coiling Devices Market, Canada, Volume (Units), Historic, 2009-2016 59
Table 25: Navigational System Market, Canada, Volume (Units), Historic, 2009-2016 61
Table 26: Embolization and Coiling Devices Market, Canada, Volume (Units), Forecast, 2016-2023 63
Table 27: Navigational System Market, Canada, Volume (Units), Forecast, 2016-2023 65
Table 28: Interventional Neurology Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 66
Table 29: Interventional Neurology Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 68
Table 30: Neurological Diagnostic Equipment Market, Canada, Segment Contribution (%), 2016 70
Table 31: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 72
Table 32: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 74
Table 33: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016 76
Table 34: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023 78
Table 35: Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 79
Table 36: Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 81
Table 37: Neurostimulation Devices Market, Canada, Segment Contribution (%), 2016 83
Table 38: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 85
Table 39: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 87
Table 40: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016 89
Table 41: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023 91
Table 42: Neurological Diagnostic Equipment Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 92
Table 43: Neurological Diagnostic Equipment Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 94
Table 44: Neurosurgical Products Market, Canada, Segment Contribution (%), 2016 97
Table 45: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 99
Table 46: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 101
Table 47: Neurosurgical Products Market, Canada, Volume (Units), Historic, 2009-2016 103
Table 48: Neurosurgical Products Market, Canada, Volume (Units), Forecast, 2016-2023 105
Table 49: Neurosurgical Products Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2015-2016 106
Table 50: Neurosurgical Products Market, Canada, Company Share by Revenue ($m), USD Constant, 2016 108
Table 51: Radiosurgery Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 109
Table 52: Radiosurgery Market, Canada, Volume (Units), Historic, 2009-2016 110
Table 53: Neurology Devices Market Pipeline Products 114
Table 54: M Pharma Raises USD1.5 Million in First Tranche of Private Placement of 10% Debentures Due 2019 118
Table 55: Sierra Oncology Prices Public Offering of Shares for USD26.3 Million 119
Table 56: Colorado State University and Synaptive Medical Enter into Partnership 121
Table 57: General Atlantic Invests in Synaptive Medical 122
Table 58: Evasc Medical Systems Raises USD7.5 Million in Series A Financing 123
Table 59: Synaptive Medical Raises USD1 Million in Venture Financing 124
Table 60: NeuroQore Secures Venture Funding from IndieBio 125
Table 61: Synaptive Medical Raises Additional USD0.3 Million in Venture Financing 126
Table 62: Synaptive Medical Raises USD3.4 Millio in Venture Financing 127
1.2 List of Figures
Figure 1: Neurology Devices Market, Canada, Revenue ($m), USD Constant, 2009-2023 13
Figure 2: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 15
Figure 3: Neurology Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 17
Figure 4: Neurology Devices Market, Canada, Volume (Units), 2009-2023 19
Figure 5: Neurology Devices Market, Canada, Volume (Units), Historic, 2009-2016 21
Figure 6: Neurology Devices Market, Canada, Volume (Units), Forecast, 2016-2023 23
Figure 7: Neurology Devices Market, Canada, Company Share (%) 2016 25
Figure 8: CSF Management Market, Canada, Revenue Mix ($m), 2016 27
Figure 9: CSF Management Market, Canada, Segment Contribution (%), 2016 28
Figure 10: CSF Management Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 29
Figure 11: CSF Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 31
Figure 12: CSF Management Market, Canada, Volume (Units), Historic, 2009-2016 33
Figure 13: CSF Management Market, Canada, Volume (Units), Forecast, 2016-2023 35
Figure 14: CSF Management Market, Canada, Company Share (%) 2016 38
Figure 15: Interventional Neurology Market, Canada, Revenue Mix ($m), 2016 40
Figure 16: Interventional Neurology Market, Canada, Segment Contribution (%), 2016 41
Figure 17: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 42
Figure 18: Interventional Neurology Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 44
Figure 19: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 46
Figure 20: Navigational System Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 48
Figure 21: Embolization and Coiling Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 50
Figure 22: Navigational System Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Figure 23: Interventional Neurology Market, Canada, Volume (Units), Historic, 2009-2016 54
igure 24: Interventional Neurology Market, Canada, Volume (Units), Forecast, 2016-2023 56
Figure 25: Embolization and Coiling Devices Market, Canada, Volume (Units), Historic, 2009-2016 58
Figure 26: Navigational System Market, Canada, Volume (Units), Historic, 2009-2016 60
Figure 27: Embolization and Coiling Devices Market, Canada, Volume (Units), Forecast, 2016-2023 62
Figure 28: Navigational System Market, Canada, Volume (Units), Forecast, 2016-2023 64
Figure 29: Interventional Neurology Market, Canada, Company Share (%) 2016 67
Figure 30: Neurological Diagnostic Equipment Market, Canada, Revenue Mix ($m), 2016 69
Figure 31: Neurological Diagnostic Equipment Market, Canada, Segment Contribution (%), 2016 70
Figure 32: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 71
Figure 33: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 73
Figure 34: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016 75
Figure 35: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023 77
Figure 36: Neurological Diagnostic Equipment Market, Canada, Company Share (%) 2016 80
Figure 37: Neurostimulation Devices Market, Canada, Revenue Mix ($m), 2016 82
Figure 38: Neurostimulation Devices Market, Canada, Segment Contribution (%), 2016 83
Figure 39: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 84
Figure 40: Neurological Diagnostic Equipment Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 86
Figure 41: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Historic, 2009-2016 88
Figure 42: Neurological Diagnostic Equipment Market, Canada, Volume (Units), Forecast, 2016-2023 90
Figure 43: Neurological Diagnostic Equipment Market, Canada, Company Share (%) 2016 93
Figure 44: Neurosurgical Products Market, Canada, Revenue Mix ($m), 2016 95
Figure 45: Neurosurgical Products Market, Canada, Segment Contribution (%), 2016 96
Figure 46: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 98
Figure 47: Neurosurgical Products Market, Canada, Revenue ($m), USD Constant, Forecast, 2016-2023 100
Figure 48: Neurosurgical Products Market, Canada, Volume (Units), Historic, 2009-2016 102
Figure 49: Neurosurgical Products Market, Canada, Volume (Units), Forecast, 2016-2023 104
Figure 50: Neurosurgical Products Market, Canada, Company Share (%) 2016 107
Figure 51: Radiosurgery Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016 109
Figure 52: Radiosurgery Market, Canada, Volume (Units), Historic, 2009-2016 110